新的含有Etodolac的醇衍生物的抗菌活性
Zahraa N Fakhreldain1, Hajer A Jawad2, Israa Sami Hadi2
1DEPARTMENT OF CLINICAL PHARMACY, FACULTY OF PHARMACY, UNIVERSITY OF KUFA, NAJAF, IRAQ.
概括
研究人员使用Etodolac合成了新的醇衍生物,并测试了它们的抗菌作用. 化合物1显示出显著的抗菌活性,特别是针对大肠杆菌,突出显示了潜在的治疗应用.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 抗菌研究 抗菌研究
背景情况:
- 埃托多拉克是一种非类固醇抗炎药物.
- 醇衍生物以其多样化的生物活性而闻名.
- 需要新的抗微生物药物来对抗耐药细菌.
研究的目的:
- 合成新型的醇衍生物,其中包括Etodolac部分.
- 为了评估合成化合物的体外抗菌活性.
- 为了确定有前途的候选人进一步药物开发.
主要方法:
- 埃托多拉克与三种芳香胺 (o-phenylene diamine,2-aminophenol,2-aminothiophenol) 反应,产生了三种新的化合物.
- 使用标准微生物分析评估了抗菌活性.
- 对于每个化合物,针对选定的细菌菌株,确定了最小抑制度 (MIC).
主要成果:
- 成功合成了三种新的醇衍生物 (化合物1-3).
- 化合物1对所有测试的病原体表现出强大的广泛抗菌活性.
- 化合物1显示出对大肠杆菌的MIC值显著低.
结论:
- 将Etodolac纳入醇衍生物合成中,可以产生具有显著抗菌潜力的化合物.
- 化合物1是作为治疗性抗微生物剂进一步研究的有希望的候选物.
- 建议进行进一步的研究,以探索这些新型化合物的作用机制和治疗疗效.
相关概念视频
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.6K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para...
3.6K
Antimicrobial Effectiveness
894
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
894
Drugs for Treatment of Ulcerative Colitis in IBD
448
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
448


